# FDA Inspection 1028577 - Ishihara Sangyo Kaisha, Ltd. - September 08, 2017

Source: https://www.keypedia.com/records/fda_inspections/ishihara-sangyo-kaisha-ltd/92560ad6-febf-447e-8d8a-e7dc9a35caf0
Source feed: FDA_Inspections

> FDA Inspection 1028577 for Ishihara Sangyo Kaisha, Ltd. on September 08, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028577
- Company Name: Ishihara Sangyo Kaisha, Ltd.
- Inspection Date: 2017-09-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1181874 - 2022-09-09](https://www.keypedia.com/records/fda_inspections/ishihara-sangyo-kaisha-ltd/eafe2d09-fccf-40b1-9ffd-cd22a4123086)
- [FDA Inspection 895933 - 2014-09-05](https://www.keypedia.com/records/fda_inspections/ishihara-sangyo-kaisha-ltd/ae2a4d6d-c903-404e-a9a7-4ed0e7a9c147)
- [FDA Inspection 747053 - 2011-09-02](https://www.keypedia.com/records/fda_inspections/ishihara-sangyo-kaisha-ltd/c317e378-08ad-44c1-b51e-40e939cf1f5d)

Company: https://www.keypedia.com/companies/ishihara-sangyo-kaisha-ltd/ccb80b55-c2c2-466b-aaae-76f386802655

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c